<DOC>
	<DOCNO>NCT00794040</DOCNO>
	<brief_summary>Severe mood dysregulation ( SMD ) common syndrome child . Its symptom include severe irritability , include persistent anger frequent outburst , well distractibility , hyperactivity , symptom attention deficit hyperactivity disorder ( ADHD ) . Many child SMD receive diagnosis bipolar disorder ( BD ) community , although clear manic episode ( symptom extreme happiness decrease need sleep ) . Because SMD study depth , know medication helpful SMD . This study evaluate effectiveness stimulant medication methylphenidate ( MPH , commonly know Ritalin ) combine ( combine ) antidepressant citalopram ( Celexa ) treat symptom SMD child adolescent . This study provide information treat SMD youth . This study include approximately 80 patient 7 17 year age SMD . The patient symptom must start age 12 . The study consist four phase carry 4 5 month . During Phase 1 , patient undergo blood urine test , gradually taper medication . The duration phase depend patient medication start study . In Phase 2 , patient remain medication 1 week . In Phase 3 , patient treat MPH 2 week , randomly assign receive either MPH plus citalopram MPH plus placebo 8 week . In Phase 4 , researcher evaluate effectiveness medication take , begin open treatment phase use medication deem appropriate patient ( may include MPH citalopram and/or medication combination ) . Most patient admit Pediatric Behavioral Health Unit National Institutes Health Clinical Center medication withdrawal part study ( Phases 1 2 ) . From Phase 3 , patient may participate inpatient , outpatient , day treatment , depend best interest .</brief_summary>
	<brief_title>A Controlled Trial Serotonin Reuptake Inhibitors Added Stimulant Medication Youth With Severe Mood Dysregulation</brief_title>
	<detailed_description>Objective : To test efficacy citalopram plus methylphenidate vs. placebo plus methylphenidate decreasing irritability youth severe mood dysregulation . Study population : Youth age 7-17 severe mood dysregulation ( SMD ) . SMD characterize nonepisodic , impair irritability ( define increase reactivity negative emotional stimulus least 3 times/week angry sad mood , day , time , noticeable others ) hyperarousal ( three : distractibility , intrusiveness , pressure speech , race thought , agitation , insomnia ) , onset age 12 . Many child receive diagnosis bipolar disorder ( BD ) community , although meet DSM-IV criterion BD lack distinct manic episode . Design : Medication withdrawal , follow 5-week dose stabilization phase methylphenidate 8-week double-blind , placebo-controlled treatment trial citalopram plus methylphenidate vs. placebo plus methylphenidate . There also optional open treatment end , patient opportunity total 10 week citalopram plus methylphenidate . The target dose citalopram 20-40 mg/day . Outcome measure : The primary outcome measure Aberrant Behavior Checklist Irritability subscale CGI-I .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Mood Disorders</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Problem Behavior</mesh_term>
	<mesh_term>Attention Deficit Disruptive Behavior Disorders</mesh_term>
	<mesh_term>Neurodevelopmental Disorders</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Serotonin Uptake Inhibitors</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>INCLUSION CRITERIA : 1 . Ages 717 2 . Abnormal mood ( specifically , anger , sadness , and/or irritability ) , present least half day day , sufficient severity noticeable people child environment ( e.g . parent , teacher , peer ) . 3 . Hyperarousal , define least three follow symptom : insomnia , agitation , distractibility , race thought flight idea , pressure speech , intrusiveness 4 . Compared his/her peer , child exhibit markedly increase reactivity negative emotional stimulus manifest verbally and/or behaviorally . For example , child responds frustration extend temper tantrum ( inappropriate age and/or precipitate event ) , verbal rage , and/or aggression toward people property . Such event occur , average , least three time week 5 . Criteria 2 , 3 , 4 currently present present least 12 month without symptomfree period exceed two month . 6 . The onset symptom must prior age 12 year . 7 . The symptom severe least one setting ( e.g . violent outburst , extreme verbal abuse , assaultiveness home , school , peer ) . In addition , least mild symptom ( distractibility , intrusiveness ) second setting . 8 . Currently treatment psychiatrist symptom . 9 . The child fail his/her treatment . To meet criterion : i.The child current CGAS score must less equal 60. ii.The child psychiatrist/treater must agree child response his/her current treatment minimal . According criterion , would clinically appropriate change child current treatment . iii.On basis record review interview child parent , research team agree child response his/her current treatment minimal . iv.The child score great 12 irritability subscale Aberrant Behavior Checklist . EXCLUSION CRITERIA : 1 . As assessed mania section KSADSPL , individual exhibit cardinal bipolar symptom distinct period last 1 day , therefore meet criteria bipolar disorder otherwise specify : ) Elevated expansive mood ii ) Grandiosity inflate selfesteem iii ) Decreased need sleep iv ) Increase goaldirected activity ( result excessive involvement pleasurable activity high potential painful consequence ) 2 . Meets criteria schizophrenia , schizophreniform disorder , schizoaffective illness , mild PDD , PTSD . 3 . Meets criteria substance use disorder three month prior randomization . 4 . IQ less 70 5 . The symptom due direct physiological effect drug abuse , general medical neurological condition . 6 . Currently pregnant lactating , sexually active without use barrier method contraception . 7 . Failed adequate trial ( define four week consecutive treatment minimally effective ) severe ill effect citalopram ( least 20 mg ) escitalopram ( least 10 mg ) . 8 . Hypersensitivity severe adverse reaction methylphenidate 9 . A history serious adverse reaction ( psychosis , severely increased activation compare baseline ) methylphenidate amphetamine . 10 . Any chronic medical condition require medication contraindicate SSRIs methylphenidate , serious chronic unstable medical disorder . 11 . Medical contraindication treatment SSRI stimulant ( e.g . liver , seizure , renal , platelet disorder ) .</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>January 30, 2017</verification_date>
	<keyword>Irritability</keyword>
	<keyword>Attention Deficit Hyperactivity Disorder</keyword>
	<keyword>Explosive</keyword>
	<keyword>Tantrums</keyword>
	<keyword>Bipolar Mood Disorder</keyword>
	<keyword>Mood Disorder</keyword>
	<keyword>Childhood Mood Disorder</keyword>
	<keyword>ADHD</keyword>
</DOC>